These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 11440361

  • 1. Physical training decreases plasma thrombomodulin in type I and type II diabetic patients.
    Rigla M, Fontcuberta J, Mateo J, Caixàs A, Pou JM, de Leiva A, Pérez A.
    Diabetologia; 2001 Jun; 44(6):693-9. PubMed ID: 11440361
    [Abstract] [Full Text] [Related]

  • 2. Normalisation of tissue factor pathway inhibitor activity after glycaemic control optimisation in type 1 diabetic patients.
    Rigla M, Mateo J, Fontcuberta J, Souto JC, de Leiva A, Pérez A.
    Thromb Haemost; 2000 Aug; 84(2):223-7. PubMed ID: 10959693
    [Abstract] [Full Text] [Related]

  • 3. Postprandial thrombin activatable fibrinolysis inhibitor and markers of endothelial dysfunction in type 2 diabetic patients.
    Rigla M, Wägner AM, Borrell M, Mateo J, Foncuberta J, de Leiva A, Ordóñez-Llanos J, Pérez A.
    Metabolism; 2006 Nov; 55(11):1437-42. PubMed ID: 17046544
    [Abstract] [Full Text] [Related]

  • 4. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
    Herlihy OM, Barrow BA, Grant PJ, Levy JC.
    Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
    [Abstract] [Full Text] [Related]

  • 5. Endothelial function and biochemical vascular markers in first-degree relatives of type 2 diabetic patients: the effect of exercise training.
    Ostergård T, Nyholm B, Hansen TK, Rasmussen LM, Ingerslev J, Sørensen KE, Bøtker HE, Saltin B, Schmitz O.
    Metabolism; 2006 Nov; 55(11):1508-15. PubMed ID: 17046554
    [Abstract] [Full Text] [Related]

  • 6. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 7. Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators.
    Zareba W, Pancio G, Moss AJ, Kalaria VG, Marder VJ, Weiss HJ, Watelet LF, Sparks CE.
    Thromb Haemost; 2001 Sep; 86(3):791-9. PubMed ID: 11583309
    [Abstract] [Full Text] [Related]

  • 8. [Plasminogen activator inhibitor (PAI-1) and markers of endothelial dysfunction in patients with diabetes mellitus].
    Galajda P, Martinka E, Baláz D, Stasko J, Kerný J, Planková E, Mokán M, Kubisz P.
    Vnitr Lek; 1997 Nov; 43(11):744-7. PubMed ID: 9650506
    [Abstract] [Full Text] [Related]

  • 9. Relationship between plasma soluble thrombomodulin levels and insulin resistance syndrome in type 2 diabetes: a comparison with von Willebrand factor.
    Aso Y, Fujiwara Y, Tayama K, Takanashi K, Inukai T, Takemura Y.
    Exp Clin Endocrinol Diabetes; 2001 Nov; 109(4):210-6. PubMed ID: 11453033
    [Abstract] [Full Text] [Related]

  • 10. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
    De Jager J, Kooy A, Lehert P, Bets D, Wulffelé MG, Teerlink T, Scheffer PG, Schalkwijk CG, Donker AJ, Stehouwer CD.
    J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
    [Abstract] [Full Text] [Related]

  • 11. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Iorio A, Federici MO, Mourvaki E, Ferolla P, Piroddi M, Stabile A, Timi A, Celleno R, Benedetti MM.
    Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
    [Abstract] [Full Text] [Related]

  • 12. Influence of ramipril on the course of plasma thrombomodulin in patients with diabetes mellitus.
    Borcea V, Morcos M, Isermann B, Henkels M, Ziegler S, Zumbach M, Amiral J, Längst KD, Seiz W, Ziegler R, Wahl P, Nawroth PP.
    Vasa; 1999 Aug; 28(3):172-80. PubMed ID: 10483322
    [Abstract] [Full Text] [Related]

  • 13. Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus.
    Gabat S, Keller C, Kempe HP, Amiral J, Ziegler R, Ritz E, Bergis KH, Wahl P, Nawroth P.
    Vasa; 1996 Aug; 25(3):233-41. PubMed ID: 8795304
    [Abstract] [Full Text] [Related]

  • 14. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A, Pérez A, Córdoba A, Arcelús R, Carreras G, de Leiva A, González-Sastre F, Blanco-Vaca F.
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [Abstract] [Full Text] [Related]

  • 15. Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.
    Leurs PB, Stolk RP, Hamulyak K, Van Oerle R, Grobbee DE, Wolffenbuttel BH.
    Diabetes Care; 2002 Aug; 25(8):1340-5. PubMed ID: 12145232
    [Abstract] [Full Text] [Related]

  • 16. Biochemical markers of endothelial activation in primary hyperparathyroidism.
    Fallo F, Cella G, Casonato A, Ermani M, Vettor R, Zanella S, Lumachi F.
    Horm Metab Res; 2006 Feb; 38(2):125-9. PubMed ID: 16523414
    [Abstract] [Full Text] [Related]

  • 17. Effects of moderate-intensity exercise training on plasma biomarkers of inflammation and endothelial dysfunction in older patients with type 2 diabetes.
    Zoppini G, Targher G, Zamboni C, Venturi C, Cacciatori V, Moghetti P, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Dec; 16(8):543-9. PubMed ID: 17126770
    [Abstract] [Full Text] [Related]

  • 18. The effects of exercise training on markers of endothelial function in young healthy men.
    O'Sullivan SE.
    Int J Sports Med; 2003 Aug; 24(6):404-9. PubMed ID: 12905087
    [Abstract] [Full Text] [Related]

  • 19. Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes.
    De Mattia G, Bravi MC, Laurenti O, Cassone-Faldetta M, Proietti A, De Luca O, Armiento A, Ferri C.
    Diabetologia; 1998 Nov; 41(11):1392-6. PubMed ID: 9833950
    [Abstract] [Full Text] [Related]

  • 20. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G.
    Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.